Share：
Share this content in WeChat
X
[Chinese][PDF]161
• Case Report •
Pancreatic myxofibrosarcoma: One case report and literature review
ZHANG Manman  LI Xu  MA Peiqi  ZHANG Xiaoyan  ZHANG Lei 

Cite this article as: ZHANG M M, LI X, MA P Q, et al. Pancreatic myxofibrosarcoma: One case report and literature review[J]. Chin J Magn Reson Imaging, 2024, 15(8): 179-180, 193. DOI:10.12015/issn.1674-8034.2024.08.027.


[Keywords] myxofibrosarcoma；pancreatic tumor；magnetic resonance imaging

ZHANG Manman   LI Xu   MA Peiqi   ZHANG Xiaoyan   ZHANG Lei*  

Department of Medical Imaging, Fuyang Hospital Affiliated to Bengbu Medical University (Fuyang People's Hospital), Fuyang 236000, China

Corresponding author: ZHANG L, E-mail: 492510404@qq.com

Conflicts of interest   None.

Received  2024-03-19
Accepted  2024-07-09
DOI: 10.12015/issn.1674-8034.2024.08.027
Cite this article as: ZHANG M M, LI X, MA P Q, et al. Pancreatic myxofibrosarcoma: One case report and literature review[J]. Chin J Magn Reson Imaging, 2024, 15(8): 179-180, 193. DOI:10.12015/issn.1674-8034.2024.08.027.

[1]
VANNI S, VITA A D, GURRIERI L, et al. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives[J/OL]. Ther Adv Med Oncol, 2022, 14: 17588359221093973 [2024-06-17]. https://pubmed.ncbi.nlm.nih.gov/35782752/. DOI: 10.1177/17588359221093973.
[2]
SBARAGLIA M, BELLAN E, DEI TOS A P. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives[J]. Pathologica, 2021, 113(2): 70-84. DOI: 10.32074/1591-951X-213.
[3]
ROLAND C L, WANG W L, LAZAR A J, et al. Myxofibrosarcoma[J]. Surg Oncol Clin N Am, 2016, 25(4): 775-788. DOI: 10.1016/j.soc.2016.05.008.
[4]
BEJI H, BOUASSIDA M, CHTOUROU M F, et al. Myxofibrosarcoma of the abdominal wall: A case report and literature review[J/OL]. Int J Surg Case Rep, 2022, 95: 107275 [2024-06-17]. https://pubmed.ncbi.nlm.nih.gov/36721186/. DOI: 10.1016/j.ijscr.2022.107275.
[5]
VAN DER HORST C A J, BONGERS S L M, VERSLEIJEN-JONKERS Y M H, et al. Overall survival of patients with myxofibrosarcomas: An epidemiological study[J/OL]. Cancers, 2022, 14(5): 1102 [2024-06-17]. https://pubmed.ncbi.nlm.nih.gov/35267410/. DOI: 10.3390/cancers14051102.
[6]
KIKUTA K, KUBOTA D, YOSHIDA A, et al. An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI[J]. Skeletal Radiol, 2015, 44(1): 55-62. DOI: 10.1007/s00256-014-1992-5.
[7]
STYLIANIDI M C, HAEBERLE L, SCHOTT M, et al. Primary thyroid gland myxofibrosarcoma: a case report and review of the literature[J/OL]. Surg Case Rep, 2022, 8(1): 139 [2024-06-17]. https://pubmed.ncbi.nlm.nih.gov/35876910/. DOI: 10.1186/s40792-022-01496-5.
[8]
SPINNATO P, SAMBRI A, FUJIWARA T, et al. Myxofibrosarcoma: clinical and prognostic value of MRI features[J]. Curr Med Imaging, 2021, 17(2): 217-224. DOI: 10.2174/1573405616999200729152135.
[9]
KE X T, LIU J Y, LAI Q Q. Research progresses of "tail sign" of myxofibrosarcoma on enhanced MRI[J]. Chin J Med Imag Technol, 2021, 37(8): 1251-1254. DOI: 10.13929/j.issn.1003-3289.2021.08.033.
[10]
WANG M L, JI Y, YAO X Z, et al. CT and MRI features of pancreatic neuroendocrine neoplasm[J]. Oncoradiology, 2021, 30(4): 245-251. DOI: 10.19732/j.cnki.2096-6210.2021.04.003.
[11]
XU Z G, TANG G J, PENG T S, et al. Pancreatic cystic lesions: imaging findings and clinical features (Part 2)[J]. Int J Med Radiol, 2020, 43(5): 596-602. DOI: 10.19300/j.2020.J18507.

PREV Quantitative evaluation of liver fibrosis by MRE and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in a rabbit model
NEXT Imaging findings of pelvic extraosseous Ewing sarcoma/primitive neuroectodermal tumor: One case report
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn